A UM investigation that began in late May 2011 eventually led to the discovery that Manuel Gerardo Pacheco, a pharmacy technician employed by UM, had been removing drugs from the cancer center’s pharmacy since November 2010 and selling them to someone outside the organization.
Investigators found Mr. Pacheco had stolen the following medications:
• Neulasta, used to reduce the risk of infection.
• Aloxi, used to treat nausea in chemotherapy patients.
• Avastin and Oxaliplatin, used to treat colon cancer.
• Rituxan, used for non-Hodgkin’s lymphoma.
• Aranesp, for chronic kidney failure.
• Velcade, used for bone-marrow cancer.
Navigant Economics, a company hired by UM for the case, estimated Mr. Pacheco stole a total of at least $14 million over the three years.
Mr. Pacheco was charged with four counts of grand theft, two counts of trafficking in contraband prescription drugs and one count of dealing in stolen property. He has pleaded not guilty, according to the report.
More Articles on University of Miami:
University of Miami Hospital Reaches Labor Deal With Union
University of Miami Medical School Layoffs Prompted by Failed Strategies, Critics Say
Jackson Health Board Votes to Escrow Payments to University of Miami
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
